Systemic Lupus Erythematosus is an autoimmune disease affecting multiple organs. Symptoms include rashes, joint pain, anemia, ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of ...

While hydroxychloroquine (HCQ) helps reduce disease flares in lupus, its effect on renal function in patients with lupus ...

Which of the statements about the 2025 guideline summary for the treatment of systemic lupus erythematosus are correct?

Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life. Damage resulting from the disease and ...

From 1955 to 1961 data on 33 pregnancies in 21 patients with systemic lupus erythematosus were available. Most of the patients were studied on the wards and in the outpatient departments of the ...

Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers ...

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease with wide-ranging clinical manifestations that can involve the CNS and PNS. In this article, Jeltsch-David and Muller ...